Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
DE0006200108
Fri, 10.01.2025
INDUS Holding AG
Company Name:
INDUS Holding AG
ISIN:
DE0006200108
Reason for the research:
Update
Recommendation:
Buy
from:
10.01.2025
Target price:
EUR 34.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Solid FY25e ahead for INDUS due to reasoned capital allocation
Topic: FY24e was clearly overshadowed [ … ]
Tue, 19.11.2024
INDUS Holding AG
Company Name:
INDUS Holding AG
ISIN:
DE0006200108
Reason for the research:
Update
Recommendation:
Buy
from:
19.11.2024
Target price:
EUR 34.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
RT feedback: Strong FCF and well filled M&A pipeline
Topic: On Monday we hosted a digital roundt [ … ]
Mon, 18.11.2024
INDUS Holding AG
Company Name:
INDUS Holding AG
ISIN:
DE0006200108
Reason for the research:
Update Q3 2024
Recommendation:
Buy
from:
18.11.2024
Target price:
34.30
Target price on sight of:
12 month
Last rating change:
no change
Analyst:
Daniel Großjohann, Thomas Schießle
2024 guidance after Q3 confirmed in key points, public share [ … ]
Wed, 13.11.2024
INDUS Holding AG
Company Name:
INDUS Holding AG
ISIN:
DE0006200108
Reason for the research:
Update
Recommendation:
Buy
from:
13.11.2024
Target price:
EUR 34.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Final Q3 results out // 2nd buyback offer announced; chg. est.
Topic: INDUS released its final Q3 nu [ … ]
Mon, 04.11.2024
INDUS Holding AG
Company Name:
INDUS Holding AG
ISIN:
DE0006200108
Reason for the research:
Update
Recommendation:
Buy
from:
04.11.2024
Target price:
EUR 34.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Case fully intact despite PW; chg. est.
Topic: On Thursday, INDUS released its preliminary Q3 sales [ … ]
Wed, 15.05.2024
INDUS Holding AG
Mixed Q1 results // strong FCF generation; chg. est.
Topic: INDUS reported a mixed Q1 with sales below but EBIT above estimates
as well as strong free cashflow supported by a lower seasonal working
capital increase.
Q1 sales decreased by 9% yoy to € 410m (eNuW: € 434m) due to customers’
current reluctance to buy and spend as a [ … ]
Fri, 22.03.2024
INDUS Holding AG
Strong FCF supports further growth; chg.
Topic: INDUS reported solid FY23 figures especially in light of the
currently challenging macro environment. Results are in line with the
preliminary numbers and FY23 guidance. Further, INDUS had its capital
markets day yesterday in Frankfurt. Here are the key takeaways:
FY23 sales came in at € 1. [ … ]
Fri, 15.03.2024
INDUS Holding AG
Bolt-on acquisitions into global megatrends; chg.
Topic: INDUS successfully completed the share repurchase program announced
on February 21st. Further, the German conglomerate expanded their portfolio
in the field of infrastructure networks and AI-based industrial automation.
Share buyback at an attractive price: During the period from Februa [ … ]
Thu, 22.02.2024
INDUS Holding AG
Solid FY23 prelims // focus on strong FCF & share buyback; chg.
Topic: While prelim. FY23 sales and EBIT came in largely as expected, the
strong FCF generation of € 190m is well above expectations. On top, INDUS
announced a 4.1% share buyback at € 23.
Preliminary FY23 sales remained stable yoy at € 1.80bn (eNuW: € 1.82 [ … ]
Wed, 17.01.2024
INDUS Holding AG
Another promising year for INDUS
Topic: While INDUS should experience some margin pressure in 2024e, the
EBIT margin is still seen to come in at 8.0%, which is the highest
operating margin since 2017. With an appealing dividend yield of 5.5%
(eNuW) and an attractive valuation of only 4.6x EV/EBITDA, the stock
remains a buy.
Normalizing margin [ … ]